ROCHESTER, NY -- (06/22/2006; 1525)(EIS) -- Upstate New Yorkers who take Zocor to lower their cholesterol could reduce their annual out-of-pocket spending by more than $9 million when the drug's patent expires June 23 and the first lower-cost generic version becomes available, Excellus BlueCross BlueShield experts predicted today.
Full text: http://www.eisinc.com/release/storiesh/EXCELL.025.html
沒有留言:
張貼留言